Neuronetics' NeuroStar Depression Therapy Not Backed By Data - Blues

Existing evidence does not support the long-term efficacy of Neuronetics' NeuroStar transcranial magnetic stimulation therapy for drug-resistant depression, according to a recent 1assessment by the Blue Cross and Blue Shield Association Technology Evaluation Center

More from Archive

More from Medtech Insight